EMA – Publication of Real-world evidence framework to support EU regulatory decision-making: 2nd report on the experience gained with regulator-led studies from February 2023 to February 2024

The EMA published its 2nd report on the Real-world evidence framework to support EU regulatory decision-making for the period between February 2023 and February 2024. This report builds on the experience previously acquired during the period from September 2021 to February 2023 in conducting regulatory-led studies using real-world data (RWD) to support EU regulatory decisions (see previous report here). It covers the period from 8 February 2023 to 7 February 2024, which corresponds to year 2...

Publication Details

Journal
Industrias Culturais (Universidade de Coimbra)
Published
2024-10-21
DOI
https://doi.org/10.58079/12jhb
Primary Topic
Pharmacovigilance and Adverse Drug Reactions
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

EMA – Publication of Real-world evidence framework to support EU regulatory decision-making: 2nd report on the experience gained with regulator-led studies from February 2023 to February 2024

Industrias Culturais (Universidade de Coimbra)
Pharmacovigilance and Adverse Drug Reactions
article

EMA – Publication of Real-world evidence framework to support EU regulatory decision-making: 2nd report on the experience gained with regulator-led studies from February 2023 to February 2024

article en

Abstract

The EMA published its 2nd report on the Real-world evidence framework to support EU regulatory decision-making for the period between February 2023 and February 2024. This report builds on the experience previously acquired during the period from September 2021 to February 2023 in conducting regulatory-led studies using real-world data (RWD) to support EU regulatory decisions (see previous report here). It covers the period from 8 February 2023 to 7 February 2024, which corresponds to year 2...

Industrias Culturais (Universidade de Coimbra)
Peace, Justice and strong institutions
Openalex Percentile: Top 66%
Pharmacovigilance and Adverse Drug Reactions
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

EMA – Publication of Real-world evidence framework to support EU regulatory decision-making: 2nd report on the experience gained with regulator-led studies from February 2023 to February 2024 · Industrias Culturais (Universidade de Coimbra) (2024) | TGRS Research Map | TGRS